A follow-up of the ShortHER trial suggests tumor-infiltrating lymphocytes (TILs) can help identify patients who may benefit ...
A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback